Keyphrases
Clinical High Risk for Psychosis (CHR-P)
100%
Gender Differences
100%
Drug Use
100%
Symptomatology
100%
Comorbidity
100%
Global Functioning
33%
Anxiety Disorders
33%
Cannabis Use
33%
Affective Disorders
33%
Substance Use Disorder
16%
General Psychopathology
16%
Psychosis
16%
Structured Interview
16%
Negative Symptoms
16%
Statistical Power
16%
Schizophrenia
16%
Healthy Controls
16%
Prodromal
16%
Negative Current
16%
Gene-environment Interaction
16%
Psychotic Disorders
16%
Chronic Schizophrenia
16%
Comorbid
16%
First-episode Psychosis
16%
Unadjusted Analyses
16%
Clinically Significant
16%
Multiple Testing
16%
European Network
16%
Early Detection
16%
Clinical Symptoms
16%
Medicine and Dentistry
Symptomatology
100%
Drug Use
100%
Sex Difference
100%
Comorbidity
100%
Cannabis Use
33%
Anxiety Disorder
33%
Psychosis
33%
Genotype Environment Interaction
16%
Substance Abuse
16%
Schizophrenia
16%
Negative Syndrome
16%
Psychology
Gender Difference
100%
Comorbidity
100%
Mental State
50%
Anxiety Disorder
33%
Mood Disorder
33%
Schizophrenia
33%
Structured Interview
16%
Gene-Environment Interaction
16%
Psychotic Disorder
16%
Substance Abuse
16%
Neuroscience
Comorbidity
100%
Cannabis
50%
Anxiety Disorder
50%
Psychosis
50%
Negative Syndrome
25%
Substance Abuse
25%
Schizophrenia
25%